Patrick Grohs

628 total citations
27 papers, 489 citations indexed

About

Patrick Grohs is a scholar working on Infectious Diseases, Clinical Biochemistry and Epidemiology. According to data from OpenAlex, Patrick Grohs has authored 27 papers receiving a total of 489 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 12 papers in Clinical Biochemistry and 11 papers in Epidemiology. Recurrent topics in Patrick Grohs's work include Bacterial Identification and Susceptibility Testing (12 papers), Antimicrobial Resistance in Staphylococcus (12 papers) and Antibiotic Resistance in Bacteria (9 papers). Patrick Grohs is often cited by papers focused on Bacterial Identification and Susceptibility Testing (12 papers), Antimicrobial Resistance in Staphylococcus (12 papers) and Antibiotic Resistance in Bacteria (9 papers). Patrick Grohs collaborates with scholars based in France. Patrick Grohs's co-authors include Laurent Gutmann, Isabelle Podglajen, Marie-Dominique Kitzis, Jean‐Luc Mainardi, Étienne Carbonnelle, Nesrine Day, Fabrice Compain, Guy Meyer, Ludwig Gutmann and Raymond Legrand and has published in prestigious journals such as Journal of Bacteriology, Journal of Clinical Microbiology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Patrick Grohs

26 papers receiving 465 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrick Grohs France 13 194 178 153 145 133 27 489
Wanita J. Howard United States 8 240 1.2× 237 1.3× 162 1.1× 211 1.5× 94 0.7× 10 544
Anita Hällgren Sweden 13 153 0.8× 241 1.4× 222 1.5× 177 1.2× 109 0.8× 28 572
Julival Ribeiro Brazil 9 188 1.0× 208 1.2× 212 1.4× 113 0.8× 131 1.0× 12 507
Gabriella Parisi Italy 10 215 1.1× 321 1.8× 212 1.4× 245 1.7× 99 0.7× 22 655
Andrea Lázár Hungary 12 134 0.7× 191 1.1× 122 0.8× 258 1.8× 99 0.7× 26 564
Michael J. Rybak United States 10 130 0.7× 181 1.0× 269 1.8× 97 0.7× 168 1.3× 18 610
Olaniyi Ayobami Germany 10 153 0.8× 287 1.6× 207 1.4× 108 0.7× 128 1.0× 14 587
Aki Hirabayashi Japan 15 85 0.4× 238 1.3× 101 0.7× 126 0.9× 110 0.8× 39 543
Isabella A. Tickler United States 14 220 1.1× 199 1.1× 444 2.9× 199 1.4× 182 1.4× 30 671
Kwang Jun Lee South Korea 12 101 0.5× 339 1.9× 107 0.7× 120 0.8× 101 0.8× 32 467

Countries citing papers authored by Patrick Grohs

Since Specialization
Citations

This map shows the geographic impact of Patrick Grohs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Grohs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Grohs more than expected).

Fields of papers citing papers by Patrick Grohs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Grohs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Grohs. The network helps show where Patrick Grohs may publish in the future.

Co-authorship network of co-authors of Patrick Grohs

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Grohs. A scholar is included among the top collaborators of Patrick Grohs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Grohs. Patrick Grohs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Holub, Michal, David Lebeaux, Patrick Grohs, et al.. (2025). Central-venous-catheter-related bloodstream infections in adult patients with sickle cell disease: a retrospective, two-centre study. European Journal of Clinical Microbiology & Infectious Diseases. 44(4). 877–886.
2.
Couturier, Jeanne, Patrick Grohs, Aurélie Vilfaillot, et al.. (2023). Prevalence and risk factors of toxigenic Clostridioides difficile asymptomatic carriage in 11 French hospitals. Frontiers in Medicine. 10. 1221363–1221363. 8 indexed citations
3.
5.
Vilfaillot, Aurélie, et al.. (2021). Appropriateness of empirical antibiotic prescription for bloodstream infections in an emergency department from 2006 to 2018: impact of the spread of ESBL-producing Enterobacterales. European Journal of Clinical Microbiology & Infectious Diseases. 41(1). 71–77. 11 indexed citations
6.
Grohs, Patrick, et al.. (2020). Comparative evaluation of the QMAC-dRAST V2.0 system for rapid antibiotic susceptibility testing of Gram-negative blood culture isolates. Journal of Microbiological Methods. 172. 105902–105902. 21 indexed citations
8.
Grohs, Patrick, P Morand, Isabelle Podglajen, et al.. (2017). In Vitro Activity of Ceftolozane-Tazobactam against Multidrug-Resistant Nonfermenting Gram-Negative Bacilli Isolated from Patients with Cystic Fibrosis. Antimicrobial Agents and Chemotherapy. 61(4). 20 indexed citations
9.
Grohs, Patrick, Isabelle Podglajen, Emmanuel Guérot, et al.. (2014). Assessment of five screening strategies for optimal detection of carriers of third-generation cephalosporin-resistant Enterobacteriaceae in intensive care units using daily sampling. Clinical Microbiology and Infection. 20(11). O879–O886. 24 indexed citations
10.
Grohs, Patrick, Solen Kernéis, Brigitte Sabatier, et al.. (2013). Fighting the spread of AmpC-hyperproducing Enterobacteriaceae: beneficial effect of replacing ceftriaxone with cefotaxime. Journal of Antimicrobial Chemotherapy. 69(3). 786–789. 32 indexed citations
11.
Grohs, Patrick, Aurore Caumont‐Prim, Étienne Carbonnelle, et al.. (2013). Comparison of Five Media for Detection of Extended-Spectrum Beta-Lactamase by Use of the Wasp Instrument for Automated Specimen Processing. Journal of Clinical Microbiology. 51(8). 2713–2716. 24 indexed citations
12.
Grohs, Patrick, Patrick Trieu‐Cuot, Isabelle Podglajen, et al.. (2012). Molecular Basis for Different Levels of tet (M) Expression in Streptococcus pneumoniae Clinical Isolates. Antimicrobial Agents and Chemotherapy. 56(10). 5040–5045. 7 indexed citations
13.
Grohs, Patrick, et al.. (2012). Readmission of known MRSA carriers and MRSA colonization pressure in hospital. Epidemiology and Infection. 141(6). 1181–1186. 4 indexed citations
14.
Grohs, Patrick, et al.. (2011). Accuracy of MIC determination for Streptococcus pneumoniae using the Sirscan2000automatic MIC determination system. Diagnostic Microbiology and Infectious Disease. 70(3). 399–403. 1 indexed citations
15.
Grohs, Patrick, B. Fantin, A. Lefort, et al.. (2010). Differences in daptomycin and vancomycin ex vivo behaviour can lead to false interpretation of negative blood cultures. Clinical Microbiology and Infection. 17(8). 1264–1267. 2 indexed citations
17.
Kac, G., Patrick Grohs, Pierre Durieux, et al.. (2007). Impact of Electronic Alerts on Isolation Precautions for Patients With Multidrug-Resistant Bacteria. Archives of Internal Medicine. 167(19). 2086–2086. 27 indexed citations
18.
Grohs, Patrick & G. Kac. (2005). Sélection de critères de doublons pertinents pour le suivi du taux de Staphylococcus aureus résistant à la méticilline. Pathologie Biologie. 53(8-9). 476–480. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026